Journal of Cellular Biochemistry · 2012 · 11 citations · 25 references
MedicineBiochemistryPharmacologyMetabolic RegulationMolecular PharmacologyPathophysiologyAdipose TissueAntiretroviral TherapyAntiviral PharmacologyAntiviral TherapyLipid MetabolismMetabolic SyndromeAdipocyte BiologyAdipocyte MetabolismAdipose Tissue DysfunctionHighly Active Antiretroviral TherapyHiv Antiretroviral TherapyHormonal Regulation Of AdipogenesisStable ExpressionTherapeutic Targeting Of Lipogenesis
The highly active antiretroviral therapy (HAART) can cause a metabolic syndrome consisting of lipodystropy/lipoatrophy, dyslipidemia, and type 2 diabetes mellitus with an increased cardiovascular risk. The pathogenetic bases of HAART-associated lipodystrophy are poorly known. A genetic screen was used to evaluate proteins that are modulated in HIV-1-infected patients with or without lipodystrophy syndrome, that are routinely treated with HAART regimens. The most significant modulation was represented by FAP48 expression. Stable over-expression of FAP48 was able to alter, in vitro, adipogenesis, acting both on calcineurin and glucocorticoid pathways. Finally, we demonstrated that FAP48 over-expression was able to influence the capacity of some HIV drugs, Saquinavir and Efavirenz, but not Stavudine, Amprenavir, and Indinavir to inhibit adipocyte formation. In conclusion, this molecule could be a potential target for novel therapeutic approaches to the HAART related lipodystrophy in HIV patients.
25
Nuclear Export of NF-ATc Enhanced by Glycogen Synthase Kinase-3
Chan Beals, Colleen M. Sheridan, Christoph W. Turck et al. · Science · 1997 · 754 citations